BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Transitions in Care in SMA Patient #1: Transition planning following adolescent diagnosis

Activity Snapshot

Activity Type: 
Print/PDF
Release Date: 
Wednesday, April 13, 2022

Faculty

John Brandsema, MD
Neuromuscular Education Director and Neuromuscular Section Head
Children’s Hospital of Philadelphia Philadelphia, PA
Activity Overview: 

This case study will explore transitions in care in SMA in patient #1 (15-year-old-male). This case will focus on transition planning following adolescent diagnosis.

Learning Objectives: 
  • Identify factors that affect disease course in spinal muscular atrophy (SMA)
    • SMA subtype, time of onset or diagnosis, vigilant respiratory and multidisciplinary care, approved therapies, etc.
  • Understand the differing needs of pediatric vs adult patients with SMA, with emphasis on the importance of psychosocial support for adult patients
  • Implement proper medical management for transitions in care, according to best practice guidelines that help address issues specifically encountered by patients with SMA